The Wild Card in This $66 Billion Health-Care Deal

Long-term investors tend not to put much weight on daily share price gyrations. CVS Health shareholders don’t have that luxury.

Read more here:: Wall Street Journal

SoftBank Ought to Back a Sprint and T-Mobile Marriage

Sprint is once again running away before exchanging vows with T-Mobile.Instead of going back and forth on the terms, SoftBank should just take the plunge.

Read more here:: Wall Street Journal

Eurozone Still Not Ticking the Inflation Box

Eurozone data suggest the was a little fortunate in the timing of its decision to slow bond purchases next year.

Read more here:: Wall Street Journal

Beating Rival Banks in Tough Times Bodes Well for BNP

Paribas’s third-quarter numbers gave investors the heebie-jeebies, but compare the French bank to its peers and there is little reason for fright.

Read more here:: Wall Street Journal

Why Asia’s Largest Oil Company Won’t Reward Investors

PetroChina, which reported sharply higher third-quarter earnings Monday, has a lot of attractive features—state financial backing, enormous reserves, and a near-monopoly in the world’s most-important natural gas growth market. But policy and market forces are shifting against it.

Read more here:: Wall Street Journal

Startups That Never Grow Up

The flood of cash into startups has allowed companies to stay private for far longer than in the past, raising the question of whether many companies are worth the $1 billion-plus values private investors have attached to them.

Read more here:: Wall Street Journal

The Savings Rate is Too Low

Heard on the Street: Americans’ low rate of personal saving is remarkable and a return to a higher level could be unpleasant for investors.

Read more here:: Wall Street Journal

A Surprising Shakeout Among Banks as Rates Rise

When the began raising interest rates, every bank was a winner. As the Fed prepares for its fifth rate boost, some banks are benefiting more than others.

Read more here:: Wall Street Journal

A Stock Market Where the Rally is Actually Deserved

European stocks have rallied sharply this year, but based on companies actually making more money, not investor appetite for ever increasing earnings multiples.

Read more here:: Wall Street Journal

HSBC Finally Finds a Taste of Growth in China

has been promising growth in and now it seems to have found some with a chunky slug of extra lending in the southern Chinese province near its stronghold.

Read more here:: Wall Street Journal

Sickly Earnings Season for Drug Stocks

This earnings season has an unhappy one for pharma investors. The NYSE Arca Pharmaceutical Index is down more than 5% over the past three weeks.

Read more here:: Wall Street Journal

Millennials Have Fallen in Love With Gucci, for Now

Classic brands often blame millennials for sales downturns, but the younger generation is giving Gucci a sensational boost. This could assure the luxury goods maker years of growth, or leave it grumbling like everyone else about that fickle group.

Read more here:: Wall Street Journal

Tech Rally Is Juiced by Highflying Cloud Business

Fast growth in cloud revenue at Amazon, Microsoft and Google gave investors reasons to bet the three tech giants could maintain their growth trajectories.

Read more here:: Wall Street Journal

At Clariant, Breaking Up Was the Easy Part

Activists prevailed in keeping Clariant independent, but now they need to come up with ideas for creating value.

Read more here:: Wall Street Journal

The Bond Selloff’s Missing Ingredient: Inflation

Better growth and tighter central bank policy are lifting bond yields, but the market lacks a critical factor for lift-off.

Read more here:: Wall Street Journal

Asia’s Rich Are Helping Swiss Bankers Recover Their Poise

Asian investors, particularly from , are helping revive from a summer stumble and its shares have further to run.

Read more here:: Wall Street Journal

Chinese Banks’ Capital Cushion Isn’t So Comfy

Banks have been issuing a huge pile of new debt to shore up their balance sheets, suggesting all is not well beneath the surface.

Read more here:: Wall Street Journal

ECB Takes a Teeny, Tiny Step Toward Ending Loose Monetary Policy

The opened the door to exiting extraordinary monetary policy but is still a long way from going through it

Read more here:: Wall Street Journal

Storms Force Insurers to Pay Up for Protection

The reinsurance industry looks like it will get a modest boost following the wave of natural disasters this year, but primary insurers may get squeezed.

Read more here:: Wall Street Journal

Celgene’s Health Scare Is a Wake Up Call for Biotechs

Celgene shareholders got some chilling news Thursday morning, sending its shares plunging 18% when trading opened—the stock’s worst decline in more than a decade.

Read more here:: Wall Street Journal